Targeted DNA RNA Sequencing Market Size, Trends, Analysis, and Outlook By Technology (NGS By Method (Exome Sequencing, Enrichment Sequencing, Amplicon Sequencing), NGS By Application (Cancer Gene Sequencing, Inherited Disease Screening, Drug Development, Forensic Genomics, 16S ribosomal RNA (rRNA) sequencing, Others)), By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Application (Human Biomedical Research, Plant & Animal Sciences, Drug Discovery, Others), By Type (DNA Based Targeted Sequencing, RNA Based Targeted Sequencing), By End-user (Academic Research, Hospitals & Clinics, Pharma & Biotech Entities, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Targeted DNA RNA Sequencing market size is poised to register 14.65% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Targeted DNA RNA Sequencing market across By Technology (NGS By Method (Exome Sequencing, Enrichment Sequencing, Amplicon Sequencing), NGS By Application (Cancer Gene Sequencing, Inherited Disease Screening, Drug Development, Forensic Genomics, 16S ribosomal RNA (rRNA) sequencing, Others)), By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Application (Human Biomedical Research, Plant & Animal Sciences, Drug Discovery, Others), By Type (DNA Based Targeted Sequencing, RNA Based Targeted Sequencing), By End-user (Academic Research, Hospitals & Clinics, Pharma & Biotech Entities, Others).
The Targeted DNA RNA Sequencing Market is witnessing growth driven by increasing demand for precision medicine and personalized genomic profiling, rising adoption of next-generation sequencing (NGS) technologies in clinical diagnostics, and advancements in sequencing library preparation and bioinformatics analysis. Targeted DNA RNA sequencing enables the selective amplification and sequencing of specific genomic regions or gene panels for identifying genetic mutations, gene fusions, and expression patterns associated with disease pathology and therapeutic response. Key trends shaping its future include the development of multiplex PCR and hybridization capture assays for targeted enrichment of DNA RNA targets with high specificity and sensitivity, integration of automated and miniaturized sequencing workflows for rapid and cost-effective sample processing, and customization of sequencing panels and bioinformatics pipelines for diverse research and clinical applications. Additionally, increasing investment in genomic medicine initiatives and precision oncology programs, expansion of molecular diagnostic laboratories and sequencing core facilities, and regulatory approvals for new targeted sequencing assays contribute to market expansion.
Targeted DNA RNA Sequencing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Targeted DNA RNA Sequencing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Targeted DNA RNA Sequencing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Targeted DNA RNA Sequencing industry.
Key market trends defining the global Targeted DNA RNA Sequencing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Targeted DNA RNA Sequencing Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Targeted DNA RNA Sequencing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Targeted DNA RNA Sequencing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Targeted DNA RNA Sequencing industry
Leading Targeted DNA RNA Sequencing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Targeted DNA RNA Sequencing companies.
Targeted DNA RNA Sequencing Market Study- Strategic Analysis Review
The Targeted DNA RNA Sequencing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Targeted DNA RNA Sequencing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Targeted DNA RNA Sequencing Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Targeted DNA RNA Sequencing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Targeted DNA RNA Sequencing market segments. Similarly, Strong end-user demand is encouraging Canadian Targeted DNA RNA Sequencing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Targeted DNA RNA Sequencing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Targeted DNA RNA Sequencing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Targeted DNA RNA Sequencing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Targeted DNA RNA Sequencing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Targeted DNA RNA Sequencing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Targeted DNA RNA Sequencing in Asia Pacific. In particular, China, India, and South East Asian Targeted DNA RNA Sequencing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Targeted DNA RNA Sequencing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Targeted DNA RNA Sequencing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Targeted DNA RNA Sequencing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Targeted DNA RNA Sequencing.
Targeted DNA RNA Sequencing Market Company Profiles
The global Targeted DNA RNA Sequencing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agilent Technologies Inc, ArcherDX Inc, BGI Group, Illumina Inc, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, PerkinElmer Inc, QIAGEN N.V., Roche Holding AG, Thermo Fisher Scientific Inc
Recent Targeted DNA RNA Sequencing Market Developments
The global Targeted DNA RNA Sequencing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Targeted DNA RNA Sequencing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others
Geographical Segmentation:
Agilent Technologies Inc
ArcherDX Inc
BGI Group
Illumina Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
QIAGEN N.V.
Roche Holding AG
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The Targeted DNA RNA Sequencing Market is witnessing growth driven by increasing demand for precision medicine and personalized genomic profiling, rising adoption of next-generation sequencing (NGS) technologies in clinical diagnostics, and advancements in sequencing library preparation and bioinformatics analysis. Targeted DNA RNA sequencing enables the selective amplification and sequencing of specific genomic regions or gene panels for identifying genetic mutations, gene fusions, and expression patterns associated with disease pathology and therapeutic response. Key trends shaping its future include the development of multiplex PCR and hybridization capture assays for targeted enrichment of DNA RNA targets with high specificity and sensitivity, integration of automated and miniaturized sequencing workflows for rapid and cost-effective sample processing, and customization of sequencing panels and bioinformatics pipelines for diverse research and clinical applications. Additionally, increasing investment in genomic medicine initiatives and precision oncology programs, expansion of molecular diagnostic laboratories and sequencing core facilities, and regulatory approvals for new targeted sequencing assays contribute to market expansion.
Targeted DNA RNA Sequencing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Targeted DNA RNA Sequencing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Targeted DNA RNA Sequencing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Targeted DNA RNA Sequencing industry.
Key market trends defining the global Targeted DNA RNA Sequencing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Targeted DNA RNA Sequencing Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Targeted DNA RNA Sequencing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Targeted DNA RNA Sequencing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Targeted DNA RNA Sequencing industry
Leading Targeted DNA RNA Sequencing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Targeted DNA RNA Sequencing companies.
Targeted DNA RNA Sequencing Market Study- Strategic Analysis Review
The Targeted DNA RNA Sequencing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Targeted DNA RNA Sequencing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Targeted DNA RNA Sequencing Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Targeted DNA RNA Sequencing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Targeted DNA RNA Sequencing market segments. Similarly, Strong end-user demand is encouraging Canadian Targeted DNA RNA Sequencing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Targeted DNA RNA Sequencing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Targeted DNA RNA Sequencing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Targeted DNA RNA Sequencing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Targeted DNA RNA Sequencing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Targeted DNA RNA Sequencing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Targeted DNA RNA Sequencing in Asia Pacific. In particular, China, India, and South East Asian Targeted DNA RNA Sequencing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Targeted DNA RNA Sequencing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Targeted DNA RNA Sequencing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Targeted DNA RNA Sequencing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Targeted DNA RNA Sequencing.
Targeted DNA RNA Sequencing Market Company Profiles
The global Targeted DNA RNA Sequencing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agilent Technologies Inc, ArcherDX Inc, BGI Group, Illumina Inc, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, PerkinElmer Inc, QIAGEN N.V., Roche Holding AG, Thermo Fisher Scientific Inc
Recent Targeted DNA RNA Sequencing Market Developments
The global Targeted DNA RNA Sequencing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Targeted DNA RNA Sequencing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Agilent Technologies Inc
ArcherDX Inc
BGI Group
Illumina Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
QIAGEN N.V.
Roche Holding AG
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Targeted DNA RNA Sequencing Market Overview and Key Findings, 2024
1.2 Targeted DNA RNA Sequencing Market Size and Growth Outlook, 2021- 2030
1.3 Targeted DNA RNA Sequencing Market Growth Opportunities to 2030
1.4 Key Targeted DNA RNA Sequencing Market Trends and Challenges
1.4.1 Targeted DNA RNA Sequencing Market Drivers and Trends
1.4.2 Targeted DNA RNA Sequencing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Targeted DNA RNA Sequencing Companies
2. TARGETED DNA RNA SEQUENCING MARKET SIZE OUTLOOK TO 2030
2.1 Targeted DNA RNA Sequencing Market Size Outlook, USD Million, 2021- 2030
2.2 Targeted DNA RNA Sequencing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. TARGETED DNA RNA SEQUENCING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. TARGETED DNA RNA SEQUENCING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Targeted DNA RNA Sequencing Market, 2025
5.2 Asia Pacific Targeted DNA RNA Sequencing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Targeted DNA RNA Sequencing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Targeted DNA RNA Sequencing Market, 2025
5.5 Europe Targeted DNA RNA Sequencing Market Size Outlook by Type, 2021- 2030
5.6 Europe Targeted DNA RNA Sequencing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Targeted DNA RNA Sequencing Market, 2025
5.8 North America Targeted DNA RNA Sequencing Market Size Outlook by Type, 2021- 2030
5.9 North America Targeted DNA RNA Sequencing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Targeted DNA RNA Sequencing Market, 2025
5.11 South America Pacific Targeted DNA RNA Sequencing Market Size Outlook by Type, 2021- 2030
5.12 South America Targeted DNA RNA Sequencing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Targeted DNA RNA Sequencing Market, 2025
5.14 Middle East Africa Targeted DNA RNA Sequencing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Targeted DNA RNA Sequencing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Targeted DNA RNA Sequencing Market Size Outlook and Revenue Growth Forecasts
6.2 US Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Targeted DNA RNA Sequencing Industry Drivers and Opportunities
7. TARGETED DNA RNA SEQUENCING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. TARGETED DNA RNA SEQUENCING COMPANY PROFILES
8.1 Profiles of Leading Targeted DNA RNA Sequencing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agilent Technologies Inc
ArcherDX Inc
BGI Group
Illumina Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
QIAGEN N.V.
Roche Holding AG
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Targeted DNA RNA Sequencing Market Overview and Key Findings, 2024
1.2 Targeted DNA RNA Sequencing Market Size and Growth Outlook, 2021- 2030
1.3 Targeted DNA RNA Sequencing Market Growth Opportunities to 2030
1.4 Key Targeted DNA RNA Sequencing Market Trends and Challenges
1.4.1 Targeted DNA RNA Sequencing Market Drivers and Trends
1.4.2 Targeted DNA RNA Sequencing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Targeted DNA RNA Sequencing Companies
2. TARGETED DNA RNA SEQUENCING MARKET SIZE OUTLOOK TO 2030
2.1 Targeted DNA RNA Sequencing Market Size Outlook, USD Million, 2021- 2030
2.2 Targeted DNA RNA Sequencing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. TARGETED DNA RNA SEQUENCING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. TARGETED DNA RNA SEQUENCING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Targeted DNA RNA Sequencing Market, 2025
5.2 Asia Pacific Targeted DNA RNA Sequencing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Targeted DNA RNA Sequencing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Targeted DNA RNA Sequencing Market, 2025
5.5 Europe Targeted DNA RNA Sequencing Market Size Outlook by Type, 2021- 2030
5.6 Europe Targeted DNA RNA Sequencing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Targeted DNA RNA Sequencing Market, 2025
5.8 North America Targeted DNA RNA Sequencing Market Size Outlook by Type, 2021- 2030
5.9 North America Targeted DNA RNA Sequencing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Targeted DNA RNA Sequencing Market, 2025
5.11 South America Pacific Targeted DNA RNA Sequencing Market Size Outlook by Type, 2021- 2030
5.12 South America Targeted DNA RNA Sequencing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Targeted DNA RNA Sequencing Market, 2025
5.14 Middle East Africa Targeted DNA RNA Sequencing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Targeted DNA RNA Sequencing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Targeted DNA RNA Sequencing Market Size Outlook and Revenue Growth Forecasts
6.2 US Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Targeted DNA RNA Sequencing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Targeted DNA RNA Sequencing Industry Drivers and Opportunities
7. TARGETED DNA RNA SEQUENCING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. TARGETED DNA RNA SEQUENCING COMPANY PROFILES
8.1 Profiles of Leading Targeted DNA RNA Sequencing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agilent Technologies Inc
ArcherDX Inc
BGI Group
Illumina Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
QIAGEN N.V.
Roche Holding AG
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
